Share-based Payment Arrangement, Expense in USD of Ginkgo Bioworks Holdings, Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ginkgo Bioworks Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to Q3 2025.
  • Ginkgo Bioworks Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $17.8M, a 28.8% increase year-over-year.
  • Ginkgo Bioworks Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $81.1M, a 39.8% decline year-over-year.
  • Ginkgo Bioworks Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $112M, a 51.1% decline from 2023.
  • Ginkgo Bioworks Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $230M, a 88.1% decline from 2022.
  • Ginkgo Bioworks Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.93B, a 14.7% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Ginkgo Bioworks Holdings, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $81.1M $17.8M +$3.99M +28.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $77.1M $22.2M -$14.9M -40.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $92M $20.4M -$20.4M -49.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $112M $20.6M -$22.3M -52% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $135M $13.9M -$38.7M -73.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $173M $37.1M -$24.3M -39.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $198M $40.8M -$32.2M -44.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 $230M $42.8M -$65.3M -60.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 $295M $52.6M -$511M -90.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $806M $61.5M -$545M -89.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.35B $73M -$580M -88.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.93B $108M -$1.56B -93.5% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 $3.49B $563M +$563M +443315% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $2.93B $607M +$592M +4077% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $2.34B $653M +$653M +553138% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $1.68B $1.67B Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $127K +$9K +7.63% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $14.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $118K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $118K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15

Ginkgo Bioworks Holdings, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $112M -$118M -51.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $230M -$1.7B -88.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $1.93B +$248M +14.7% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 $1.68B +$1.68B +353380% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $476K -$295K -38.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-13
2019 $771K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.